The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland

Table 4

Logistic regression analyses of the biomarkers serum concentrations in the psoriasis without arthritis and psoriatic arthritis compared to the control group.

Biomarker	Analysis of effects	Psoriasis without arthritis versus control		Psoriatic arthritis versus control
		OR (95% CI)		OR (95% CI)
sRANKL (pmol/L)	0.277	1.001 (0.993, 1.010)	0.736	1.007 (0.998, 1.015)	0.138
COMP (ng/mL)	0.022	1.003 (1.001, 1.005)	0.007	1.001 (0.999, 1.003)	0.332
Osteoprotegerin (pmol/L)	0.085	1.825 (1.049, 3.178)	0.033	1.818 (0.999, 3.307)	0.050
Osteoprotegerin/sRANKL	0.057	1.043 (0.996, 1.092)	0.074	0.956 (0.876, 1.044)	0.319
IL-20 (pg/mL)	<0.001	1.241 (1.123, 1.372)	<0.001	1.218 (1.101, 1.348)	<0.001